Comparative outcomes between empagliflozin and dapagliflozin in heart failure: real world multi-center cohort study

被引：0
|
作者：
Bu, S. [1 ]
Ahn, H. S. [1 ]
Jung, M. H. [2 ]
Lee, D. [3 ]
Hwang, Y. M. [4 ]
Cho, J. S. [5 ]
Yi, J. E. [6 ]
Kim, H. [7 ]
Kim, S. [8 ]
Kim, S. H. [9 ]
机构：
[1] Uijeongbu St Marys Hosp, Uijongbu, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[3] Incheon St Marys Hosp, Incheon, South Korea
[4] St Vincents Hosp, Suwon, South Korea
[5] Daejeon St Marys Hosp, Daejeon, South Korea
[6] Eunpyeong St Marys Hosp, Seoul, South Korea
[7] Yeoido St Marys Hosp, Seoul, South Korea
[8] Bucheon St Marys Hosp, Bucheon, South Korea
[9] Seoul Natl Univ Hosp, Hlth promot Ctr, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
    Modzelewski, Katherine L.
    Pipilas, Alexandra
    Bosch, Nicholas A.
    JAMA NETWORK OPEN, 2024, 7 (05) : E249305
  • [2] Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
    Hakansson, Erik
    Norberg, Helena
    Sjalander, Sara
    Lindmark, Krister
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [3] Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population
    Thorvaldsen, Tonje
    Ferrannini, Giulia
    Mellbin, Linda
    Benson, Lina
    Cosentino, Francesco
    Mcmurray, John J., V
    Dahlstrom, Ulf
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (07) : 1050 - 1062
  • [4] Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study
    Kocabas, Umut
    Ergin, Isil
    Yavuz, Veysel
    Altin, Cihan
    Kaplan, Mehmet
    Oztekin, Gulsum Meral Yilmaz
    Dogdus, Mustafa
    Murat, Selda
    Murat, Bektas
    Kivrak, Tarik
    Karabulut, Dilay
    Kaya, Ersin
    Ozdemir, Ibrahim Halil
    Yildiz, Cennet
    Salkin, Fatma Ozge
    Ozcalik, Emre
    Polatkan, Seyda Gunay
    Cakan, Fahri
    Sen, Taner
    Karabulut, Umut
    Cakal, Sinem
    Oflar, Ersan
    Sinan, Umit Yasar
    Yenercag, Mustafa
    Turk, Ugur Onsel
    ESC HEART FAILURE, 2025, 12 (01): : 434 - 446
  • [5] Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure (vol 7, e249305, 2024)
    Modzelewski, K. L.
    Pipilas, A.
    Bosch, N. A.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [6] Characterizing Progressive Pulmonary Fibrosis in a Multi-center Real World Cohort
    Swaminathan, A. C.
    Stevens, S. R.
    Burg, C. A.
    Best, J. H.
    Kennedy, C. C.
    Scholand, M.
    Horowitz, J. C.
    Lipchik, R. J.
    Soskis, A.
    Aronson, K. I.
    Marsolo, K.
    Gebre, E.
    Qualls, L.
    Palmer, S. M.
    Wruck, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): A Multi-Center, Retrospective, Observational Study
    Yoo, Byung-Su
    Oh, Jaewon
    Hong, Bum-Kee
    Shin, Dae-Hee
    Bae, Jang-Ho
    Yang, Dong Heon
    Shim, Wan-Joo
    Kim, Hyung-seop
    Kim, Su-Hong
    Choi, Jin-Oh
    Chun, Woo-Jung
    Go, Choong-Won
    Kang, Hyun-Jae
    Baek, Sang Hong
    Cho, Jang-hyun
    Hong, Suk-Keun
    Shin, Joon-Han
    Oh, Seok-Kyu
    Pyun, Wook-Bum
    Kwan, Jun
    Hong, Young-Joon
    Jeong, Jin-Ok
    Kang, Seok-Min
    Choi, Dong-Ju
    PLOS ONE, 2014, 9 (01):
  • [8] Compare the generalizability of dapagliflozin and empagliflozin heart failure phase three trials to real-world patients in Taiwan
    Yen, Po-Cheng
    Chang, Kai-Cheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 392 - 392
  • [9] COMPARATIVE COST EFFECTIVENESS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Gravlee, E.
    Prajapati, P.
    VALUE IN HEALTH, 2022, 25 (07) : S409 - S410
  • [10] Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study
    Engstrom, Arvid
    Soderling, Jonas
    Hviid, Anders
    Eliasson, Bjorn
    Gudbjornsdottir, Soffia
    Wintzell, Viktor
    Hveem, Kristian
    Jonasson, Christian
    Melbye, Mads
    Pasternak, Bjorn
    Ueda, Peter
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 432 - 443
12345